This course has expired. View available courses.
Endocrinology
Intensificación del tratamiento
La diabetes de tipo 2 es una enfermedad común que se controla en la atención primaria. Aunque las guías de práctica clínica recomiendan objetivos específicos en cuanto a la presión arterial, el colesterol de las LDL y la HbA1c, la investigación de atención primaria ha demostrado que solo una pequeña parte de los pacientes con […]
DURATION
30 min
PROFESSION
Physician, Nursing, Student, Specialist
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2023-02-08
La diabetes de tipo 2 es una enfermedad común que se controla en la atención primaria. Aunque las guías de práctica clínica recomiendan objetivos específicos en cuanto a la presión arterial, el colesterol de las LDL y la HbA1c, la investigación de atención primaria ha demostrado que solo una pequeña parte de los pacientes con diabetes de tipo 2 cumplen estos objetivos. En las Normas de atención médica en diabetes de 2021 de la American Diabetes Association (ADA) se recomienda que los pacientes cumplan los objetivos glucémicos, pero hay un mayor enfoque en la selección de antihiperglucemiantes que puedan mejorar los resultados en pacientes con diabetes.
En este módulo se hará énfasis en ofrecer recomendaciones sobre la intensificación del tratamiento con antihiperglucemiantes más allá de la metformina en personas con diabetes de tipo 2.
Este programa ha recibido una subvención educativa sin restricciones o apoyo en especie de Novo Nordisk A/S.
Faculty
Roopa Mehta, MBBS, MRCP
Graciela Alexanderson, MD, MACP
Learning objectives
Al finalizar este programa de formación continua, los participantes serán más capaces de hacer lo siguiente:
- Aplicar las Normas de atención médica en diabetes de 2021 de la American Diabetes Association (ADA) en el algoritmo del tratamiento de la diabetes para controlar a las personas con diabetes de tipo 2.
- Discutir la selección de antihiperglucemiantes en pacientes con enfermedades cardiovasculares y renales crónicas.
- Personalizar el tratamiento con antihiperglucemiantes según las preferencias de la persona con diabetes.
# of credits: 0
Duration: 30 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
